Csii investor relations
WebNov 9, 2024 · Q1 FY22: U.S. Coronary 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue. 2 Includes coronary orbital atherectomy devices, Coronary ViperWire, ViperSlide and other 3 Includes Sapphire angioplasty balloons and Teleport microcatheters Modest Y/Y growth despite regional … WebNov 9, 2024 · Cardiovascular Systems, Inc. (NASDAQ:NASDAQ:CSII) Q1 2024 Results Earnings Conference Call November 9, 2024 9:00 AM ETCompany ParticipantsJack …
Csii investor relations
Did you know?
WebFeb 17, 2024 · Investor Relations Cardiovascular Systems Inc CSII Executive Morningstar Rating Rating as of Feb 17, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability ... WebJan 9, 2024 · 2024 Worldwide revenue of $330.4 million – an increase of 20.4% year over year 2024 U.S. revenue of $277.2 million – an increase of 21.0% year over year 2024 International revenue of $53.2 million – an increase of 17.7% in 2024 MASON, Ohio --(BUSINESS WIRE)--Feb. 21, 2024-- AtriCure, Inc.
WebMar 29, 2024 · The Cardiovascular Systems stock price fell by -0.101% on the last day (Wednesday, 29th Mar 2024) from $19.86 to $19.84. During the last trading day the stock fluctuated 0.252% from a day low at $19.84 to a day high of $19.89. The price has risen in 4 of the last 10 days and is up by 0.4% over the past 2 weeks. WebApr 7, 2024 · See the latest Cardiovascular Systems Inc stock price (NASDAQ:CSII), related news, valuation, dividends and more to help you make your investing decisions.
WebCorporate Governance. Cardiovascular Systems, Inc.’s ISS Governance QualityScore as of April 1, 2024 is 2. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 5; … WebAug 3, 2024 · This document is intended to be read by investors in advance of regularly scheduled quarterly conference calls and was designed to provide a review of Glaukos Corporation’s recent financial and operational performance and general business outlook. Please see “Forward-Looking Statements” and “Statement Regarding Use of Non-GAAP …
WebApr 6, 2024 · Investor Relations Investor Relations NASDAQ: CSII 19.88 +0.01 0.05% Minimum 20 min delay 04/04/23 CSI Home News Releases Stock Information Financial …
WebIn depth view into CSII (Cardiovascular Systems) stock including the latest price, news, dividend history, earnings information and financials. Cardiovascular Systems Inc (CSII) 19.76 0.00 (0.00%) USD NASDAQ Mar 21, 13:33 dermaquest cbd replenishing eye creamWebQ2 FY22: U.S. Coronary 1 Is the total of Orbital Atherectomy System Revenue plus Interventional Support Device Revenue. 2 Includes coronary orbital atherectomy devices, Coronary ViperWire, ViperSlide and other 3 Includes Sapphire angioplasty balloons and Teleport microcatheters Modest Q/Q growth as COVID weighed on procedure volumes 5 … chronology of middle earth booksWebVice President, Investor Relations & Corporate Communications Jeffrey W. Chambers, M.D. Chief Medical Officer Joined CSI in 2024 Rejoined CSI in 2024 Joined CSI in 2015 Joined CSI in 2014 Sandra M. Sedo Chief Compliance Officer Andrew P. O’Brien Vice President, Information Technology Jeffrey S. Points Chief Financial Officer der marathon 2022Web2 days ago · Read the Investor Relations section for CSI, a medical device company focused on developing and commercializing innovative solutions. chronology of metal gearWebCardiovascular Systems, Inc.'s (NASDAQ:CSII) Intrinsic Value Is Potentially 42% Above Its Share Price. Simply Wall St. Jun-02-21 07:00AM. Cardiovascular Systems, Inc. to Participate at the Raymond James Human Health Innovations Conference. Business Wire. Cardiovascular Systems, Inc., a medical technology company, develops and … chronology of modern historyWebFeb 17, 2024 · Learn about the executive team and board of directors at Cardiovascular Systems Inc (CSII:XNAS) and review their bios and compensation over the latest fiscal … der marathon paterWebApr 11, 2024 · DermTech Announces Release Date for Fourth-Quarter 2024 Financial Results. Feb 09, 2024. der marathon-mann